Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa

mBio

Volumn 5, Issue 5, 2014, Pages

  Markussen, Trine ^a   Marvig, Rasmus Lykke ^a   Gómez Lozano, María ^a   Aanæs, Kasper ^b   Burleigh, Alexandra E ^a   Høiby, Niels ^b,c   Johansen, Helle Krogh ^b   Molin, Søren ^a   Jelsbak, Lars ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B;

ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FUSA1 GENE; GENE EXPRESSION; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; GYRA GENE; GYRB GENE; HOST PATHOGEN INTERACTION; HUMAN; MICROBIAL DIVERSITY; MUTATION RATE; NONHUMAN; NONSENSE MUTATION; PHENOTYPIC VARIATION; PHYLOGENETIC TREE; PHYLOGENY; POPULATION STRUCTURE; PREVALENCE; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; ADAPTATION; CLASSIFICATION; CYSTIC FIBROSIS; DNA SEQUENCE; ENVIRONMENT; GENETICS; GENOMICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR CLONING; MOLECULAR EVOLUTION; PHENOTYPE; PHYSIOLOGY; POPULATION GENETICS; PSEUDOMONAS INFECTION; QUORUM SENSING; RESPIRATORY SYSTEM; SPUTUM;

PSEUDOMONAS AERUGINOSA;

ADAPTATION, PHYSIOLOGICAL; CLONING, MOLECULAR; CYSTIC FIBROSIS; ENVIRONMENT; EVOLUTION, MOLECULAR; GENES, BACTERIAL; GENETICS, POPULATION; GENOMICS; HOST-PATHOGEN INTERACTIONS; HUMANS; PHENOTYPE; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUORUM SENSING; RESPIRATORY SYSTEM; SEQUENCE ANALYSIS, DNA; SPUTUM;

EID: 84908425385     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01592-14     Document Type: Article

References (51)

1. Høiby N. 2011. Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med. 9:32. http://dx.doi.org/ 10.1186/1741-7015-9-32.
2. Nguyen D, Singh PK. 2006. Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc. Natl. Acad. Sci. U. S. A. 103:8305-8306. http://dx.doi.org/10.1073/pnas.0602526103.
3. Marvig RL, Johansen HK, Molin S, Jelsbak L. 2013. Genome analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLOS Genet. 9:e1003741. http://dx.doi.org/10.1371/journal.pgen.1003741.
4. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 103:8487-8492. http://dx.doi.org/10.1073/pnas.0602138103.
5. Cramer N, Klockgether J, Wrasman K, Schmidt M, Davenport CF, Tümmler B. 2011. Microevolution of the major common Pseudomonas aeruginosa clones C and PA14 in cystic fibrosis lungs. Environ. Microbiol. 13:1690-1704. http://dx.doi.org/10.1111/j.1462-2920.2011.02483.x.
6. Wilder CN, Allada G, Schuster M. 2009. Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect. Immun. 77:5631-5639. http:// dx.doi.org/10.1128/IAI.00755-09.
7. Rau MH, Hansen SK, Johansen HK, Thomsen LE, Workman CT, Nielsen KF, Jelsbak L, Høiby N, Yang L, Molin S. 2010. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ. Microbiol. 12:1643-1658.
8. Hansen SK, Rau MH, Johansen HK, Ciofu O, Jelsbak L, Yang L, Folkesson A, Jarmer HØ, Aanæs K, von Buchwald C, Høiby N, Molin S. 2012. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J. 6:31-45. http://dx.doi.org/10.1038/ismej.2011.83.
9. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, Brockhurst MA, Winstanley C. 2011. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am. J. Respir. Crit. Care Med. 183:1674 -1679. http://dx.doi.org/10.1164/ rccm.201009-1430OC.
10. Workentine ML, Sibley CD, Glezerson B, Purighalla S, Norgaard-Gron JC, Parkins MD, Rabin HR, Surette MG. 2013. Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One 8:e60225. http://dx.doi.org/10.1371/journal.pone.0060225.
11. Chung JC, Becq J, Fraser L, Schulz-Trieglaff O, Bond NJ, Foweraker J, Bruce KD, Smith GP, Welch M. 2012. Genomic variation among contemporary Pseudomonas aeruginosa isolates from chronically infected cystic fibrosis patients. J. Bacteriol. 194:4857- 4866. http://dx.doi.org/ 10.1128/JB.01050-12.
12. Lieberman TD, Flett KB, Yelin I, Martin TR, McAdam AJ, Priebe GP, Kishony R. 2014. Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. Nat. Genet. 46:82-87. http://dx.doi.org/10.1038/ng.2848.
13. Yang L, Jelsbak L, Marvig RL, Damkiær S, Workman CT, Rau MH, Hansen SK, Folkesson A, Johansen HK, Ciofu O, Høiby N, Sommer MO, Molin S. 2011. Evolutionary dynamics of bacteria in a human host environment. Proc. Natl. Acad. Sci. U. S. A. 108:7481-7486. http:// dx.doi.org/10.1073/pnas.1018249108.
14. Qin X, Zerr DM, McNutt MA, Berry JE, Burns JL, Kapur RP. 2012. Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients. Antimicrob. Agents Chemother. 56:5971-5981. http://dx.doi.org/10.1128/AAC.01371-12.
15. Ciofu O, Mandsberg LF, Bjarnsholt T, Wassermann T, Høiby N. 2010. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants. Microbiology 156(Pt 4):1108 -1119. http://dx.doi.org/10.1099/ mic.0.033993-0.
16. Jelsbak L, Johansen HK, Frost AL, Thøgersen R, Thomsen LE, Ciofu O, Yang L, Haagensen JA, Høiby N, Molin S. 2007. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect. Immun. 75:2214-2224. http://dx.doi.org/ 10.1128/IAI.01282-06.
17. Drummond AJ, Suchard MA, Xie D, Rambaut A. 2012. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 29: 1969-1973. http://dx.doi.org/10.1093/molbev/mss075.
18. Oliver A, Cantón R, Campo P, Baquero F, Blázquez J. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-1254. http://dx.doi.org/10.1126/ science.288.5469.1251.
19. Pedersen SS, Høiby N, Espersen F, Koch C. 1992. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax 47:6-13. http://dx.doi.org/10.1136/thx.47.1.6.
20. Martin DW, Schurr MJ, Mudd MH, Govan JR, Holloway BW, Deretic V. 1993. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 90: 8377-8381. http://dx.doi.org/10.1073/pnas.90.18.8377.
21. Yang L, Haagensen JA, Jelsbak L, Johansen HK, Sternberg C, Høiby N, Molin S. 2008. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J. Bacteriol. 190:2767-2776. http://dx.doi.org/10.1128/JB.01581-07.
22. Hoffman LR, Kulasekara HD, Emerson J, Houston LS, Burns JL, Ramsey BW, Miller SI. 2009. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J. Cyst. Fibros. 8:66-70. http://dx.doi.org/10.1016/j.jcf.2008.09.006.
23. Mahenthiralingam E, Campbell ME, Speert DP. 1994. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 62:596-605.
24. Thøgersen JC, Mørup M, Damkiaer S, Molin S, Jelsbak L. 2013. Archetypal analysis of diverse Pseudomonas aeruginosa transcriptomes reveals adaptation in cystic fibrosis airways. BMC Bioinformatics 14:279. http:// dx.doi.org/10.1186/1471-2105-14-279.
25. Huse HK, Kwon T, Zlosnik JE, Speert DP, Marcotte EM, Whiteley M. 2010. Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. mBio 1(4):e00199-10.
26. Bielecki P, Lukat P, Hüsecken K, Dötsch A, Steinmetz H, Hartmann RW, Müller R, Häussler S. 2012. Mutation in elongation factor G confers resistance to the antibiotic argyrin in the opportunistic pathogen Pseudomonas aeruginosa. Chembiochem 13:2339-2345.
27. Pasca MR, Dalla Valle C, De Jesus Lopes Ribeiro AL, Buroni S, Papaleo MC, Bazzini S, Udine C, Incandela ML, Daffara S, Fani R, Riccardi G, Marone P. 2012. Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates. Microb. Drug Resist. 18:23-32. http://dx.doi.org/10.1089/mdr.2011.0019.
28. Rainey PB, Travisano M. 1998. Adaptive radiation in a heterogeneous environment. Nature 394:69-72. http://dx.doi.org/10.1038/27900.
29. Hansen SK, Rainey PB, Haagensen JA, Molin S. 2007. Evolution of species interactions in a biofilm community. Nature 445:533-536. http:// dx.doi.org/10.1038/nature05514.
30. Boles BR, Thoendel M, Singh PK. 2004. Self-generated diversity produces "insurance effects" in biofilm communities. Proc. Natl. Acad. Sci. U. S. A. 101:16630-16635. http://dx.doi.org/10.1073/pnas.0407460101.
31. Kinnersley MA, Holben WE, Rosenzweig F. 2009. E unibus plurum: genomic analysis of an experimentally evolved polymorphism in Escherichia coli. PLoS Genet. 5:e1000713. http://dx.doi.org/10.1371/ journal.pgen.1000713.
32. Herron MD, Doebeli M. 2013. Parallel evolutionary dynamics of adaptive diversification in Escherichia coli. PLoS Biol. 11:e1001490. http:// dx.doi.org/10.1371/journal.pbio.1001490.
33. Willner D, Haynes MR, Furlan M, Schmieder R, Lim YW, Rainey PB, Rohwer F, Conrad D. 2012. Spatial distribution of microbial communities in the cystic fibrosis lung. ISME J. 6:471- 474. http://dx.doi.org/ 10.1038/ismej.2011.104.
34. Bjarnsholt T, Jensen PØ, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, Pressler T, Givskov M, Høiby N. 2009. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44:547-558. http://dx.doi.org/10.1002/ppul.21011.
35. Boles BR, Singh PK. 2008. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc. Natl. Acad. Sci. U. S. A. 105:12503-12508. http://dx.doi.org/10.1073/pnas.0801499105.
36. Bjedov I, Tenaillon O, Gérard B, Souza V, Denamur E, Radman M, Taddei F, Matic I. 2003. Stress-induced mutagenesis in bacteria. Science 300:1404-1409. http://dx.doi.org/10.1126/science.1082240.
37. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van Gennip M, Ciofu O, Mandsberg L, Kharazmi A, Döring G, Givskov M, Høiby N, Jensen PØ. 2010. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65:57- 62. http://dx.doi.org/10.1136/ thx.2009.114512.
38. Johansen HK, Aanaes K, Pressler T, Nielsen KG, Fisker J, Skov M, Høiby N, von Buchwald C. 2012. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J. Cyst. Fibros. 11:525-531. http://dx.doi.org/10.1016/ j.jcf.2012.04.011.
39. Ciofu O, Johansen HK, Aanaes K, Wassermann T, Alhede M, von Buchwald C, Høiby N. 2013. P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs. J. Cyst. Fibros. 12:729 -736. http:// dx.doi.org/10.1016/j.jcf.2013.02.004.
40. Høiby N, Frederiksen B. 2000. Microbiology of cystic fibrosis, p 83-107. In Hodson ME and Geddes DM (ed), Cystic fibrosis, 2nd ed. Arnold, London, United Kingdom.
41. Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, Morales G, Köhler T, van Delden C, Weinel C, Slickers P, Tümmler B. 2007. Population structure of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 104:8101-8106. http://dx.doi.org/10.1073/pnas.0609213104.
42. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18:821- 829. http:// dx.doi.org/10.1101/gr.074492.107.
43. Fitch WM. 1971. Toward defining the course of evolution: minimum change for a specific tree topology. Syst. Zool. 20:11.
44. Swofford DL. 2003. PAUP* phylogenetic analysis using parsimony (* and other methods), version 4.0. Sinauer Associates, Sunderland, MA.
45. Yang Z, Bielawski JP. 2000. Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 15:496 -503. http://dx.doi.org/10.1016/ S0169-5347(00)01994-7.
46. Bochner BR. 2003. New technologies to assess genotype-phenotype relationships. Nat. Rev. Genet. 4:309 -314. http://dx.doi.org/10.1038/ nrg1046.
47. Bochner BR. 2009. Global phenotypic characterization of bacteria. FEMS Microbiol. Rev. 33:191-205. http://dx.doi.org/10.1111/j.1574- 6976.2008.00149.x.
48. Cooper VS, Lenski RE. 2000. The population genetics of ecological specialization in evolving Escherichia coli populations. Nature 407:736-739. http://dx.doi.org/10.1038/35037572.
49. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5:R80. http://dx.doi.org/10.1186/gb-2004-5-10-r80.
50. Clark JD, Maaloe O. 1967. DNA replication and the cell cycle in Escherichia coli cells. J. Mol. Biol. 23:99-112.
51. Hentzer M, Riedel K, Rasmussen TB, Heydorn A, Andersen JB, Parsek MR, Rice SA, Eberl L, Molin S, Høiby N, Kjelleberg S, Givskov M. 2002. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 148:87-102.